Earnings Feed
Start Free
$ADMA·8-K

ADMA BIOLOGICS, INC. · Mar 27, 7:05 AM ET

Compare

ADMA BIOLOGICS, INC. 8-K

Research Summary

AI-generated summary

Updated

ADMA Biologics Issues Press Release Under Regulation FD

What Happened

  • On March 27, 2026, ADMA Biologics, Inc. (ADMA) filed a Form 8-K reporting a Regulation FD disclosure: the company issued a press release that is furnished as Exhibit 99.1 and incorporated by reference in the filing.

Key Details

  • Filing date: March 27, 2026 (Form 8-K, Item 7.01).
  • Disclosure type: Regulation FD press release furnished as Exhibit 99.1.
  • The filing also includes an interactive XBRL cover page (Exhibit 104).

Why It Matters

  • This 8-K notifies investors that ADMA publicly released information via a press release on March 27, 2026. Investors should read the attached Exhibit 99.1 press release to see the specific news or updates the company disclosed.

Loading document...